Martin H. Schuler
Essen, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 269 publications
Pre-existing systemic immune state and dynamic myeloid remodeling shape response to neoadjuvant PD-L1 blockade.
Journal: Journal for immunotherapy of cancer
Published: July 31, 2026
Erdafitinib in Patients With Advanced Solid Tumors With FGFR Alterations (RAGNAR): Results of Tumor-Specific Analyses and Secondary Cohorts.
Journal: JCO precision oncology
Published: July 15, 2026
Impact of COPD on Outcomes After Pulmonary Metastasectomy: A Propensity-Score Matched Analysis.
Journal: Cancers
Published: June 29, 2026
Phase 3 Study of Niraparib-Plus-Pembrolizumab as Maintenance Therapy for Advanced/Metastatic Non-Small Cell Lung Cancer (ZEAL-1L).
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: May 14, 2026
Patient-reported outcomes with tarlatamab in extensive-stage small cell lung cancer after platinum-based chemotherapy: results from the phase 3 DeLLphi-304 trial.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: May 08, 2026
An Immuno-Infrared Sensor Detects Preclinical Alzheimer's and Parkinson's Disease by Protein Misfolding.
Journal: The journal of physical chemistry. B
Published: April 24, 2026
LLM-Generated Lay-Language Protocols for Molecular Tumor Board Patients: Evaluation of Quality and Clinical Usability.
Journal: Journal of medical Internet research
Published: April 22, 2026
Illuminating native fluorescence signatures for cancer detection.
Journal: Proceedings of SPIE--the International Society for Optical Engineering
Published: April 08, 2026
Phase I/Ib study evaluating safety, efficacy, pharmacokinetics and pharmacodynamics of NIZ985 monotherapy and in combination with an anti-PD-1 agent in patients with advanced solid tumors or lymphoma.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 07, 2026
Long-term follow-up of a phase 1/2 trial of anti-GDF-15 antibody visugromab plus anti-PD-1 antibody nivolumab in anti-PD-1/-L1 relapsed/refractory solid tumors.
Journal: Journal of hematology & oncology
Published: March 25, 2026
SSTR-Targeted Radiotheranostics in Breast Cancer: A Comparison of [68Ga]Ga-DOTATOC and [68Ga]Ga-SSO120 with [18F]FDG PET.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: March 14, 2026
Automated Tumor International Classification of Diseases Coding of Real-World Pathology Reports Using Self-Hosted Large Language Models.
Journal: JCO clinical cancer informatics
Published: March 11, 2026
Last Updated: 09/26/2026